Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer

Claudine Isaacs, Pia Herbolsheimer, Minetta C. Liu, Mary Wilkinson, Yvonne Ottaviano, Gina G. Chung, Robert Warren, Jennifer Eng-Wong, Philip Cohen, Karen L. Smith, Karen Creswell, Antonella Novielli, Rebecca Slack

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint Dive into the research topics of 'Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences